CARD15 polymorphisms in Behçet's disease

Scandinavian Journal of Rheumatology

Volumn 34, Issue 3, 2005, Pages 233-237

  Ahmad, Tariq ^a   Zhang, L ^a   Gogus, F ^b   Verity, D ^c   Wallace, G ^c   Madanat, W ^d   Fayyad, F ^d   James, T ^e   Neville, M ^a   Kanawati, C ^f   Fortune, F ^g   Celik, A ^b   Stanford, M ^c   Jewell, D P ^a   Marshall, S E ^h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d JORDAN HOSPITAL   (Jordan)

^e CALDERDALE ROYAL HOSPITAL   (United Kingdom)

^f St John Ophthalmic Hospital   (Israel)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B51 ANTIGEN;

ALLELE; ARTICLE; BEHCET DISEASE; CARD15 GENE; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; ENTERITIS; ETHNIC GROUP; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ARABS; BEHCET SYNDROME; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B ANTIGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JORDAN; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; TURKEY;

EID: 22144462514     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740510018714     Document Type: Article

References (15)

1. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335:1078-80.
2. Sakane T, Takeno MNS, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-91.
3. Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies-a novel serologic marker for Behcet's disease. Clin Exp Rheumatol 2002;20:S21-4.
4. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 1997;38:411-22.
5. Gul A, Inane M, Ocal L, Aral O, Konice M. Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 2000;59:622-5.
6. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-72.
7. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-18.
8. Ahmad T, Marshall S, Jewell D. Genotype based phenotyping heralds a new taxonomy for IBD. Curr Opin Gastroenterol 2003;19:327-35.
9. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, et al. Gene-environmental interaction modulated by allelic heterogeneity in inflammatory bowel diseases. Proc Natl Acad Sci USA 2003;100:3455-60.
10. Karasneh J, Gul A, Ollier WE, Silman AJ. Whole genome screening of multicase families with Behcet's disease. Proceedings of the 10th international conference on Behcet's disease, Berlin, 2002; Kluwer Academic Press, 2003.
11. Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003;48:807-13.
12. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
13. Yim CW, White RH. Behcet's syndrome in a family with inflammatory bowel disease. Arch Intern Med 1985; 145:1047-50.
14. Uyar FA, Saruhan-Direskeneli G, Gul A. Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behcet's disease in Turkey. Clin Exp Rheumatol 2004;22:S50-2.
15. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.